← Retour aux articles

health

Health & Medicine

The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.

HIGH confiance neutral ton

Couverture (757 articles)

Nous contacter FAQ